We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$5.11B
AUM Growth
-$389M
Cap. Flow
-$172M
Cap. Flow %
-3.36%
Top 10 Hldgs %
34.24%
Holding
140
New
1
Increased
36
Reduced
60
Closed
5

Top Sells

Rank Stock Value
1
SSTK icon
Shutterstock
SSTK
+$42.9M
2
RBC icon
RBC Bearings
RBC
+$26.9M
3
SPSC icon
SPS Commerce
SPSC
+$22.4M
4
RGEN icon
Repligen
RGEN
+$18.2M
5
DH icon
Definitive Healthcare
DH
+$14.7M

Sector Composition

Rank Sector Weight
1 Industrials 34.02%
2 Technology 28.27%
3 Healthcare 18.4%
4 Consumer Discretionary 5.65%
5 Materials 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HEI.A icon
51
HEICO Corp Class A
HEI.A
$37.2B
$20.5M 0.4%
178,965
+2,450
+1% +$295K
TYL icon
52
Tyler Technologies
TYL
$12.8B
$20.4M 0.4%
58,657
+1,283
+2% +$477K
WSO icon
53
Watsco Inc
WSO
$13.6B
$19.3M 0.38%
74,847
+1,390
+2% +$377K
GGG icon
54
Graco
GGG
$13.5B
$18.8M 0.37%
313,080
+4,452
+1% +$286K
TECH icon
55
Bio-Techne
TECH
$11.3B
$18.6M 0.36%
262,060
+4,384
+2% +$379K
MTN icon
56
Vail Resorts
MTN
$5.3B
$16.7M 0.33%
77,264
+1,100
+1% +$250K
SSTK icon
57
Shutterstock
SSTK
$219M
$16.6M 0.33%
331,741
-746,320
-69% -$42.9M
IT icon
58
Gartner
IT
$11.7B
$16M 0.31%
57,815
+815
+1% +$228K
WST icon
59
West Pharmaceutical
WST
$24.9B
$14.8M 0.29%
60,073
+1,140
+2% +$347K
EVI icon
60
EVI Industries
EVI
$180M
$13M 0.25%
714,428
-62,691
-8% -$740K
TFX icon
61
Teleflex
TFX
$5.98B
$12.1M 0.24%
59,853
+915
+2% +$219K
GWRE icon
62
Guidewire Software
GWRE
$14.2B
$11.5M 0.23%
187,087
+4,995
+3% +$361K
BFAM icon
63
Bright Horizons
BFAM
$3.86B
$11M 0.22%
191,221
+6,550
+4% +$498K
CGNX icon
64
Cognex
CGNX
$11.3B
$11M 0.22%
265,367
+6,515
+3% +$295K
LCII icon
65
LCI Industries
LCII
$2.65B
$10.5M 0.21%
103,441
+1,665
+2% +$202K
FIVN icon
66
FIVE9
FIVN
$2.54B
$9.95M 0.19%
132,666
+4,360
+3% +$424K
CDNA icon
67
CareDx
CDNA
$2.42B
$9.88M 0.19%
580,533
-369,165
-39% -$7.92M
GNRC icon
68
Generac Holdings
GNRC
$12.5B
$7.83M 0.15%
43,943
+715
+2% +$164K
LSPD icon
69
Lightspeed Commerce
LSPD
$1.35B
$5.02M 0.1%
285,625
+22,875
+9% +$457K
DGII icon
70
Digi International
DGII
$3.1B
$2.04M 0.04%
59,090
-17,585
-23% -$546K
PLMR icon
71
Palomar
PLMR
$3.45B
$1.84M 0.04%
21,932
-2,545
-10% -$187K
NVEE
72
DELISTED
NV5 Global
NVEE
$1.83M 0.04%
59,168
BLFS icon
73
BioLife Solutions
BLFS
$1.7B
$1.66M 0.03%
72,927
-8,620
-11% -$184K
KIDS icon
74
OrthoPediatrics
KIDS
$595M
$1.49M 0.03%
32,183
SSTI icon
75
SoundThinking
SSTI
$103M
$1.37M 0.03%
47,735

Similar funds

Conestoga Capital Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Conestoga Capital Advisors held 140 positions worth $5.11B, down 7.1% from $5.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Conestoga Capital Advisors withdrew a net $172M in Q3 2022, closing 5 positions and reducing 60 holdings. Its most notable exit was AptarGroup, an estimated $14.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 34% of assets, up from 33% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Conestoga Capital Advisors opened a new position in Olo Inc worth $770K.

  • Conestoga Capital Advisors's largest Q3 2022 buy was Olo Inc: 97,530 shares worth $770K.
  • Conestoga Capital Advisors added most to Stevanato in Q3 2022, an estimated $28.4M increase.
  • Conestoga Capital Advisors's biggest Q3 2022 reduction was Shutterstock, cutting an estimated $42.9M.
  • Conestoga Capital Advisors fully exited AptarGroup in Q3 2022, selling an estimated $14.1M.
  • Conestoga Capital Advisors's ten largest holdings make up 34% of its $5.11B portfolio in Q3 2022.
  • Conestoga Capital Advisors opened 1 new position and closed 5 in Q3 2022.
  • Conestoga Capital Advisors's portfolio value fell 7.1% quarter-over-quarter to $5.11B.

Based on Conestoga Capital Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.